Trials / Completed
CompletedNCT00594048
The Effects of Device-guided Breathing Exercises on Blood Pressure in Patients With Hypertension
The Effects of Device-guided Breathing Exercises on Blood Pressure in Patients With Hypertension. A Randomized, Single-blind, Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Medical Research Foundation, The Netherlands · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether breathing-exercises with the Resperate or listening to a discman with freely chosen music are effective in the treatment of hypertension
Detailed description
Hypertension is an important risk factor for the development of macrovascular events. Lowering blood pressure leads to a reduced risk of developing these complications. To treat hypertension effectively you can use blood pressure lowering drugs, but it is also important to use proven and safe non-pharmacological interventions. It is suggested that Breathing Rate and Systolic Blood Pressure can be linked directly together by the baroreflex. With the use of the Resperate, people will lower their breathing rate by breathing similar to music patterns which could theoretically lead, through the described link, to blood pressure reduction. Patients will be randomize into two groups: one will get a discman with freely chosen music and the other the Resperate. Patients are instructed to use the breathing device or discman for 15 minutes at about the same time every day during the 9 week study period, except for the first week.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Resperate | Use of the device 15 minutes a day for 9 weeks |
| DEVICE | discman with freely chosen music | Use the discman 15 minutes a day for 9 weeks |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2008-01-15
- Last updated
- 2011-10-26
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00594048. Inclusion in this directory is not an endorsement.